# Visit Capture P2-F2-01 — final independent closure PASS receipt

> **Checkpoint date:** 2026-10-09 Asia/Nicosia.
> **Provenance:** independent focused closure result supplied by the Product Owner to the Cockpit coordinator. This receipt records the received review; it is not a second review or author self-certification.
> **Review:** VISIT CAPTURE P2-F2-01 FOCUSED CLOSURE.
> **Verdict:** **PASS / COMPLETE_FOR_DECLARED_SCOPE**.
> **P0:P1:P2:** **0:0:0**.
> **Original P2-F2-01:** **CLOSED**.
> **Reviewed branch/head:** `feat/cockpit-visit-capture-v1-2026-10-08` @ `ad0b17912e5df719f6bbd13d9ae00b8c7c10c83f`.
> **Corrected runtime/test head:** `07f68a2adc4664a4ab050b3fa10a663de591b662`.
> **Original frozen runtime/test head:** `4646c923c728fd8613632db42e919687fc945504`.
> **Remote main as reported and coordinator-fresh-confirmed:** `045798dfa28612b268f16a99262c6ecc9ca4829d`.
> **Request:** `cockpit/reviews/VISIT_CAPTURE_P2_F2_01_FOCUSED_CLOSURE_REVIEW_REQUEST_2026-10-09.md` — `e8a479cfbc014e70f72312d866cc1dddb2abf735`.
> **Code blob:** `clinical_data.py` — `ea9e3d39c124136f4818094aec4086e49cbd0919`.
> **Test blob:** `test_visit_capture.py` — `00adc97ec0c726cc4a063470cf7a77e6f134a711`.
> **CI:** `37963002895`, job `113930287188`, SUCCESS on corrected exact head.

## Received closure dispositions

- **C1 PASS — contract:** `VisitCaptureExternalDependency` forbids extra fields and bounds `actor` (1–80) and `condition` (1–240), while accepting the declared object or null. Valid, unexpected nested, and oversized inputs are tested.
- **C2 PASS — persistence:** Save uses the typed candidate and validated `model_dump`; pending persistence serializes the typed dependency. Valid values roundtrip through saved encounter and pending record; rejected data create neither record. The responsible role remains separate from the external dependency.
- **C3 PASS — exact evidence:** the CI job checked out corrected head and passed Python syntax, JavaScript syntax, 20 focused/UI/Home tests, and diff hygiene. Eight following commits were reported as CURRENT/review docs-only, preserving tested runtime.
- Original F1/F3/F4/F5/F6 PASS are inherited unchanged. No new affected material defect identified.

## Cumulative R2 disposition and STOP

The initial post-code R2 was **BLOCK 0:0:1**, solely for **P2-F2-01**, with the other declared questions PASS. The single authorized bounded correction and this single independent affected closure **PASS 0:0:0** close the material finding and terminate the R2 review chain under `PROCEDURES.md` P5/P5.1.

**No further review or reassurance testing is required solely for this closure.** This disposition is for the approved synthetic/manual implementation only, not permission to activate real Dia/Heidi/GESY, Gmail, Zadarma or identifiable patient data.

## Operational separation

- **IMPLEMENTED / FOCUSED TESTED / INDEPENDENT R2 CLOSED.**
- **NOT MERGED / NOT DEPLOYED / NOT PRODUCT-SMOKE-VERIFIED / NOT REAL-PATIENT QUALIFIED.**
- Writer is released. Next separate lane: **release-readiness decision** and Product Owner authorization for a controlled PR/merge/deploy path, with production access and live-data activation gates explicitly distinguished.
- No existing PR #138 (draft design) merge is assumed. PR #138 remains an independent unmerged documentation/design ancestor until separately handled.

**STOP.**
